Alqahtani Mohammed S, Kazi Mohsin, Alsenaidy Mohammad A, Ahmad Muhammad Z
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Front Pharmacol. 2021 Feb 19;12:618411. doi: 10.3389/fphar.2021.618411. eCollection 2021.
The oral route is the most common route for drug administration. It is the most preferred route, due to its advantages, such as non-invasiveness, patient compliance and convenience of drug administration. Various factors govern oral drug absorption including drug solubility, mucosal permeability, and stability in the gastrointestinal tract environment. Attempts to overcome these factors have focused on understanding the physicochemical, biochemical, metabolic and biological barriers which limit the overall drug bioavailability. Different pharmaceutical technologies and drug delivery systems including nanocarriers, micelles, cyclodextrins and lipid-based carriers have been explored to enhance oral drug absorption. To this end, this review will discuss the physiological, and pharmaceutical barriers influencing drug bioavailability for the oral route of administration, as well as the conventional and novel drug delivery strategies. The challenges and development aspects of pediatric formulations will also be addressed.
口服途径是最常用的给药途径。由于其具有非侵入性、患者依从性好以及给药方便等优点,它是最受青睐的途径。多种因素影响口服药物的吸收,包括药物溶解度、黏膜通透性以及在胃肠道环境中的稳定性。克服这些因素的尝试主要集中在理解限制药物总体生物利用度的物理化学、生化、代谢和生物学屏障。人们已经探索了不同的制药技术和药物递送系统,包括纳米载体、胶束、环糊精和脂质载体,以提高口服药物的吸收。为此,本综述将讨论影响口服给药途径药物生物利用度的生理和制药屏障,以及传统和新型药物递送策略。儿科制剂的挑战和发展方面也将予以探讨。